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Introduction: Conventionally cultured mouse bone marrow mesenchymal stromal cells (mBM-MSC) are a
heterogeneous population that often initially contain contaminating haematopoietic cells. Variability in isolation
methods, culture protocols and the lack of specific mBM MSC markers might explain this heterogeneity. The aim of
this study is to optimise the isolation, culture conditions and selection of mBM-MSC.
Methods: Mouse BM-MSCs were isolated from crushed long bones (cBM) or flushed bone marrow (fBM) from 6–8
week old C57Bl/6 mice. These subpopulations were analysed by flow cytometry using commonly used mBM-MSC
cell surface marker, e.g. Sca-1, CD29 and CD44. Cells were cultured and expanded in vitro in hypoxic conditions of
either 2 % or 5 % oxygen. Cell sorting and qRT-PCR was used to determine transcript levels of stem cell and
lineage related genes in individual subpopulations.
Results: During early passaging not only do contaminating haematopoietic cells disappear, but there is a change in
the phenotype of mBM-MSC affecting particularly CD44 and Sca-1 expression. By fluorescence activated cell sorting
of CD45−/Ter119− mBM stroma based on Sca-1 expression and expansion in hypoxic conditions, we show that
Sca-1+ cells had higher CFU-F frequencies and showed enhanced proliferation compared with Sca-1− cells. As
evaluated by in vitro assays and qRT-PCR, these cells presented in vitro tri-lineage differentiation along osteocyte,
chondrocyte, and adipocyte lineages. Finally, by prospective isolation of Sca-1+PDGFRα+CD90+ cells we have
isolated mBM-MSC on a single cell level, achieving a CFU-F frequency of 1/4. Functional investigations
demonstrated that these MSC clones inhibited T-lymphocyte proliferation.
Conclusion: By positive selection using a combination of antibodies to Sca-1, CD90 and PDGFRα and culturing in
hypoxia, we have found a subpopulation of BM cells from C57Bl/6 mice with a CFU-F cloning efficiency of 1/4. To
our knowledge these results represent the highest frequencies of mouse MSC cloning from C57Bl/6 mice yet
reported.Introduction
Mesenchymal stromal cells (MSCs) are used in many
research fields and have generated much interest for cell
therapies because of their ability to differentiate into
various cell types including osteocytes, chondrocytes and
adipocytes [1]. While a lot is known about the in-vitro
behaviour of mouse and human MSCs, relatively little is* Correspondence: rhodri.ceredig@nuigalway.ie
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article, unless otherwise stated.known about the in-vivo behaviour of human MSCs.
This difference is despite the fact that human MSCs are
being used therapeutically in a number of clinical trials.
Prospective isolation of both human and mouse MSCs
(mMSCs) has been reported but is rarely undertaken.
The lack of a reliable method to prospectively isolate
mMSCs from bone marrow restricts the use of genetic-
ally altered mouse strains to study basic aspects of MSC
biology [2]. The aim of this study is to optimise the iso-
lation, culture conditions and selection of mouse bone
marrow-derived MSCs (mBM-MSCs).
A key aspect in the investigation of mBM-MSCs is the
isolation method employed. Normally, suspensions oficle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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non-adherent cells discarded during passaging. Two
common problems associated with this isolation method
are, firstly, in early passages there is contamination with
adherent haematopoietic cells and, secondly, both mes-
enchymal and haematopoietic cells in such cultures are
heterogeneous [3]. Microscopic examination of the ad-
herent mesenchymal cells show them growing from indi-
vidual foci, or colonies, and these colonies have been
called the colony-forming unit fibroblast (CFU-F) [4].
Difficulties associated with culturing mBM-MSCs as well
as mouse strain variations in plating efficiency and the
relative ease with which human cells can be cultured
have resulted in comparatively more work being done
with human MSCs than with mouse-derived MSCs
[5, 6]. By culturing adherent cells from both species long
term, it became evident that their self-renewal and/or
differentiation capacity became impaired [7]. Thus, the
MSC-like properties of cells may not be retained after
serial passaging in vitro. In order to try and improve the
isolation of mBM-MSCs, flow cytometry (FCM) has re-
cently been employed to positively select mBM-MSCs.
Several surface markers have been used in these experi-
ments, the most frequent being Stem cell antigen-1
(Sca-1) [8].
Discovered almost 30 years ago as antigens expressed
by fetal thymocytes [9], Sca-1 (Ly-6A/E) and stem cell
antigen-2 are members of the Ly-6 family of interferon-
inducible lymphocyte activation proteins whose genes
are located on mouse chromosome 15 [10, 11]. Sca-1 is
an 18 kDa mouse glycosylphosphatidylinositol (GPI)-
linked cell surface protein and is encoded by the mouse
strain-specific Ly-6A/E allelic gene [12]. Sca-1 is differ-
entially expressed by lymphocytes from mouse strains
differing at the Ly-6 locus resulting in a 20-fold higher
expression in C57Bl/6 mice (Ly-6b) compared with
BALB/c mice (Ly-6a) [13]. In the cell membrane, Sca-1
is associated with protein tyrosine kinases and lipid rafts,
suggesting that it may be involved in signal transduction
[14, 15]. In C57Bl/6 mice, Sca-1 is a well-established
marker of mouse haematopoietic stem cells (HSCs) and
in conjunction with additional markers such as CD117
(c-kit) is routinely used for their isolation from bone
marrow [16]. Likewise, for mBM-MSC isolation, Sca-1
has been used in conjunction with other markers, but
no systematic analysis of Sca-1 expression by cultured
mBM-MSCs has so far been reported. Outside the well-
characterised haematopoietic system, Sca-1 is expressed
by a mixture of stem, progenitor and differentiated cell
types in various organs such as bone, bone marrow,
muscle, thymus, spleen, kidney and lymph nodes [17].
Sca-1 has been used in combination with other markers
to isolate mBM-MSCs [18, 19], and a recent study was
able to generate clonal subpopulations of mBM-MSCsby combining Sca-1 and platelet-derived growth factor
receptor alpha (PDGFRα) staining which showed tri-
lineage differentiation capacity both in vitro and in vivo
[20].
Traditionally, mBM-MSCs are grown in vitro in ‘nor-
moxic’ conditions (21 % oxygen). This level of oxygen
does not reflect the physiological level in the bone mar-
row, thereby exposing cells to a higher oxygen concen-
tration than in their native state. Owing to its
architecture of medullary sinuses and arteries, the oxy-
gen tension in the bone marrow has been estimated to
range from 1 to 7 % [21]. For several stem and progeni-
tor populations, hypoxia is an important factor in stem
cell biology, promoting an undifferentiated state [22, 23].
Previous publications have shown that CFU-F frequency,
growth and differentiation of mBM-MSCs were nega-
tively affected by normoxic oxygen levels [24–26]. More-
over, expansion of mBM-MSCs in low-oxygen limits the
accumulation of chromosomal aberrations, a common
problem in mBM-MSC cultures [27]. Despite these
negative effects of high-oxygen cultures, low-oxygen cul-
ture conditions have not been generally adopted.
In this study we have looked systematically at the evo-
lution of surface markers on mBM-MSCs. We show that
markers commonly used for both human and mouse-
derived MSC validations, including the mouse marker
Sca-1, are upregulated during in-vitro expansion. Cells
capable of forming CFU-F were found in both Sca-1+
and Sca-1− subpopulations, but these differed in average
colony size and culturing cells under hypoxia improved
their plating efficiency. In addition, analysis of freshly
isolated and cultured Sca-1+ and Sca-1− fractions
showed significant differences in transcriptomic profiles
and differentiation properties. By combining selection
for Sca-1+ with CD90+ and PDGFRα+, we obtained a
fraction representing 0.02 % of bone marrow which had
immunosuppressive properties and a plating efficiency
of one in four sorted cells. To our knowledge, this repre-
sents one of the highest reported frequencies of CFU-F




Experimental animals were housed in a specific
pathogen-free facility and fed a standard chow diet. All
animal procedures were carried out under licence from
the Irish Department of Health and Children and were
approved by the NUI Galway Animal Care Research Eth-
ics Committee (ID: 12/JULY/02). Femurs and tibias from
6–8-week-old C57Bl/6 mice were dissected and bone
marrow flushed with an 18-gauge needle and syringe
containing α-MEM+GlutaMAX (Gibco, Paisley, UK).
Red blood cell lysis was performed using sterile water
Baustian et al. Stem Cell Research & Therapy  (2015) 6:151 Page 3 of 13for 5 seconds, after which the reaction was quenched
using fluorescence-activated cell sorting (FACS) buffer.
For the purposes of this manuscript, this cell suspension
will be referred to as flushed bone marrow (fBM).
To isolate endosteal lining cells, bone marrow was flushed
from femurs and tibias, the bones were crushed with a pestle
and mortar, were gently washed with α-MEM+GlutaMAX,
and were filtered through a 70 μm cell strainer (Fisher Scien-
tific Waltham, MA, USA). Bone fragments were further
cut into 1–2 mm pieces and incubated for 45 minutes at
37 °C in 4 ml α-MEM+GlutaMAX containing 2.5 mg/ml
collagenase I (Sigma-Aldrich, St. Louis, USA) and 100 μg/ml
DNAse IV (Sigma, St. Louis, USA). Then 10 ml α-MEM+
GlutaMAX with 10 % equine serum, 10 % fetal calf serum
and 100 units/μg penicillin/streptomycin were added to
quench collagenase activity. Finally, the suspension was fil-
tered with a 40 μm cell strainer and centrifuged at 400 × g
for 5 minutes. For the purposes of this manuscript, this sus-
pension will be referred to as compact bone marrow (cBM).
Cell pellets were resuspended in mMSC medium,
FACS buffer (1× phosphate-buffered saline (PBS), 2 %
fetal calf serum (FCS), 0.05 % NaN2) or FACS sorting
buffer (1× Ca and Mg-free PBS (Gibco-Invitrogen, Paisley,
UK), 1 % FCS, 25 mM HEPES, 2 mM sodium ethylenedi-
amine tetraacetic acid (Na2EDTA)) depending on the
intended application.
mBM-MSC culture conditions
The fBM and cBM derived cell suspensions were plated
on 10 mm plates in α-MEM+GlutaMAX supplemented
with 10 % equine serum, 10 % fetal calf serum and
100 units/μg penicillin/streptomycin (mMSC medium).
Cells were incubated in a humidified incubator at 37 °C
supplemented with either 21 %, 5 % or 2 % oxygen. At
3-day or 4-day intervals, the media were changed and
non-adherent haematopoietic cells were removed by
gentle pipetting. At 10–14 days, when the primary cul-
ture was approximately 80 % confluent, cells were de-
tached with trypsin/EDTA for 5 minutes and seeded to
new plates. Culture medium was changed every 3–4
days thereafter and subsequent passages were performed
when cells reached 60–80 % confluency. Primary articu-
lar chondrocytes were prepared from adult C57Bl/6 mice
as described previously [28] and were cultured for
10 days prior to RNA extraction.
Flow cytometry and FACS
Adherent cells were detached with 0.25 % trypsin/0.02 %
EDTA, suspended in ice-cold FACS buffer at 106 cells/ml,
and incubated for 30 minutes at 4 °C with monoclonal
antibodies (listed in Additional file 1). Cells were stained
with propidium iodide (PI) (1 μg/ml; Sigma Aldrich) prior
to FCM analysis. The FCM analysis was performed using
an Accuri® C6 Sampler flow cytometer (Becton DickinsonBiosciences, Erembodegem, Belgium), which was cali-
brated according to the manufacturer’s recommendations.
The BD Accuri® C6 Sampler is a dual-laser cytometer,
containing a 488 nm laser and a 640 nm laser and four
fluorescence detectors: FL1 (533 ± 30 nm), FL2 (585 ±
40 nm) FL3 (>670 nm) and FL4 (675/42 nm). The BD
Accuri® C6 Sampler is a digital cytometer equipped with
linear amplifiers and 24-bit digitisation on all detectors.
Data are stored and displayed in 16.7 million channels
(approximately 7.2 log display). Fluorescence compensa-
tion was set using single-stained controls, and matching
median compensation algorithms were applied. Data were
analysed using CFlowPlus (Becton Dickinson Biosciences)
or FlowJo® software (TreeStar Inc., Olten, Switzerland).
Typical gating strategies involved gating on size versus
granularity (Forward Scatter (FSC) versus Side Scatter
(SSC)), doublet exclusion based on FSC-H versus FSC-A,
and dead cell exclusion by gating on cell populations
negative for PI fluorescence in FL3. Fluorescent minus
one or matched antibody isotype controls were used to
define the position of the gates (see Additional file 2).
For FACS, the labelled cells were washed twice, filtered
through a 40 μm filter, resuspended in FACS sorting
buffer at concentrations of between 10 × 106 and 20 ×
106 cells/ml and sorted using a FACSAriaII® sorter (Bec-
ton Dickinson Biosciences). Where appropriate, the pur-
ity of sorted cell subsets was determined by post-sorting
analysis. Additional FACS information can be found in
Additional files 3 and 4).
CFU-F assay
Fluorescence-activated sorted cells isolated from fBM
and cBM were plated into a 10 mm plate and incubated
for 10 days in a humidified incubator at 37 °C, supplied
with 5 % carbon dioxide and either 21 %, 5 % or 2 %
oxygen. Subsequently, colonies were fixed and stained
with crystal violet. The number of colonies displaying 50
or more cells with spindled mMSC morphology was scored
using the Kodak Imager Software (Carestream, Kodak,
Rochester, NY, USA) on the Kodak Imager Station 4000MM
(Corestream Health Inc., Rochester, NY, USA). Colonies
with an area below 1 mm2 were scored as ‘small’, and col-
onies with an area above 1 mm2 were scored as ‘large’.
Differentiation assays
Tri-lineage differentiation capacity was determined using
standard chondrogenic, adipogenic and osteogenic dif-
ferentiation assays [23].
Quantitative RT-PCR
Total cellular RNA was extracted using TRIzol reagent
(Invitrogen, Paisley, UK) according to the manufacturer’s
instructions. Reverse transcription reactions were per-
formed with total RNA ≥20 ng/μl using the High Capacity
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Technologies, Carlsbad, CA, USA), in accordance with the
manufacturer’s instructions. Real-time PCR (Lightcycler
480II; Roche, Basel, Switzerland) was performed with 2 μl
single-stranded cDNA sample with SYBR Green PCR mas-
ter mix (Applied Biosystems). The sequences of primers
used are shown in Additional file 5. The annealing
temperature was 60 °C. Each amplification reaction was
checked to confirm the absence of nonspecific PCR product
by melting curve analysis. The relative gene expression level
was calculated and presented with the 2–ΔΔCt method. Beta-
2 microglobulin (β2M) was used as an endogenous control
to normalise specific gene expression in each sample.
Mixed lymphocyte reaction assay
cBMMSC clones, derived from single cell sorts, were added
in graded numbers to 96-well round-bottom plates and
allowed to adhere for 24 hours prior to the addition of
mouse splenocytes. The splenocytes were prepared from
C57Bl/6 mice as described previously [29]. Cells were
labelled using the CellTrace™ CFSE cell proliferation kit as
per the manufacturer’s instructions (Molecular Probes®, Life
Technologies, Carlsbad, CA, USA). Then 105 CFSE-labelled
splenocytes were added to each well, T cells were stimulated
with 0.5 μg/ml purified anti-mouse CD3 and CD28 anti-
bodies (Affymetrix eBioscience, Santa Clara, CA, USA) and
the co-cultures were incubated for 3 days. After incubation,
cells were labelled with anti-mouse CD4-PE and CD8-APC
antibodies (Becton Dickinson Biosciences) and T-cell prolif-
eration was examined via flow cytometric analysis.
Statistical analysis
All experiments were repeated at least three times with in-
dependently collected samples and all values are displayed
as mean ± standard deviation (SD) unless stated otherwise.
Statistical comparisons were analysed with the Student’s t
test or one-way analysis of variance (ANOVA) (GraphPad
Prism v6; GraphPad Software Inc., La Jolla, CA, USA) and
p <0.05 was considered statistically significant.
Results
Effect of culture duration on surface marker expression
Initial experiments were performed with cells processed
from mouse cBM. Cells were cultured under hypoxic
(5 % oxygen) conditions and after 7 days were collected
and passaged. At this time (passage 1) they exhibited a
fibroblast-like morphology typical of mMSCs. When
analysed for CD45 expression, mMSC cultures contained
>50 % CD45+ haematopoietic cells (Fig. 1a), in agreement
with previously published reports [30, 31]. Subsequent
passaging in hypoxia resulted in a significant reduction in
contaminating CD45+ cells (Fig. 1a, b).
The relative size (FSC-A) forward scatter area scaling
and granularity (SSC-A) side scatter area scaling of theCD45+ and CD45− cell populations were compared
(Fig. 1c). CD45+ and CD45− cells were indistinguishable
by FSC-A, but CD45− cells had a consistently higher
relative SSC-A value (1.5 ± 0.2) and this ratio remained
unchanged with subsequent passaging (see Figure S2A
in Additional file 6). Additional phenotypic analysis
showed that CD45+ cells in these early passage cultures
were mostly F4/80+CD31− myeloid cells (Figure S2B in
Additional file 6).
Flow cytometric analysis was performed on CD45−
cells using markers commonly used to characterise
human MSCs, namely CD73, CD90 and CD105 [32].
Results obtained showed that there was a significant
increase in the percentage of cells expressing CD73,
from 6 % at passage 1 to 47 % at passage 3. In addition,
the percentage of cells expressing CD105 increased from
20 % to 42 %. CD90 expression decreased slightly from
92 % to 85 %, over three passages (Fig. 1d). Multi-colour
flow cytometric analysis of CD73 and CD90 expression
allowed further characterisation of the observed pheno-
typic heterogeneity. As shown in Fig. 1e (left panel), at
passage 1 88 % cells were CD90+ and CD73− whereas
CD90− cells could be subdivided into 60 % CD73+ and
40 % CD73− subsets. By passage 3 (Fig. 1e, right panel) the
16 % CD90− cells were mostly CD73+ and the CD90−CD73−
cells (lower left quadrant) had essentially disappeared.
CD105 and CD73 exhibited a similar staining progression
(data not shown). Thus, as summarised in Fig. 1e, there is
clearly a phenotypic evolution of surface marker expression
on CD45− cells cultured under hypoxic conditions.
Expression of the same surface markers was analysed
on cells freshly isolated from cBM and fBM. As shown
in Fig. 1f, most gated CD45−/Ter119− cells were CD90−
CD73− and most of the CD90+ cells were CD73−.
Figure 1e and f indicates that CD90−CD73− cells do
not persist under these in-vitro culture conditions.
Sca-1 is a marker frequently used in characterising
mMSCs, particularly in C57Bl\6 mice. Given the heteroge-
neous staining pattern by cultured cells observed, we
wished to investigate the phenotypic evolution further. The
staining distribution of Sca-1 on both fBM (Fig. 1g, upper
panels) and cBM (Fig. 1g, middle panels) was initially quite
broad. Although Sca-1− cells remained negative for Sca-1
at passage 1, 90 % expressed this marker by passage 2. At
this time, expression of Sca-1 was uniform on both sub-
populations (Fig. 1g, lower panels). Surprisingly, for both
fBM and cBM, CD44 expression was initially negative on
Sca-1+ and only weakly expressed by Sca-1− cells (Fig. 1g,
middle column). Upon culture, there was an increase in
CD44 expression by both subpopulations. CD29 was
expressed on both Sca-1+ and Sca-1− cells, with a broader
staining on freshly-isolated Sca-1+ cells (Fig. 1g, upper right
panels). After culturing, CD29 was uniformly highly
expressed by both subpopulations (Fig. 1g, lower panels).
Fig. 1 Effect of culture duration on surface marker expression. a Flow cytometric analysis of CD45 expression by cBM cultures. Histograms show
CD45 staining at the indicated passage numbers with the percent positive cells in each panel (white, solid line, CD45; tinted, dashed line, isotype
control). b Summary of CD45 distribution at different passages. Values represent mean ± SD of at least three experiments. Significance testing was
done using one-way ANOVA. *p <0.05, **p <0.01. c Cytogram display of FSC-A versus SSC-A for different CD45 subpopulations (grey, CD45−; black,
CD45+). CD45+ cells have lower SSC signals than CD45− cells. d Human MSC marker expression of gated CD45− cells from cBM during in-vitro
passaging. Values represent mean ± SD of at least three experiments. Significance testing was done between passage 1 and passage 3 for CD73
(#), CD90 and CD105 (*). #/*p <0.05, Student’s t test. e Cytogram displaying the distribution of CD73 versus CD90 over passaging. Quadrants were
placed based upon negative control samples in the lower left quadrant. The percent positive cells in each quadrant are shown. f Pie-chart representation
of the distribution for CD73 versus CD90 of freshly-isolated cBM and fBM. Lower right panel shows the colour codes used to define the four
subpopulations expressing CD73 or CD90. g Phenotypic evolution of mMSC markers: Sca-1 (left), CD44 (middle) and CD29 (right), in Sca-1
defined subpopulations in freshly-isolated cBM and fBM and cultured cBM preparations. Cultured cBM (lower panels) has been expanded in-vitro for
two passages. cBM compact bone marrow, fBM flushed bone marrow
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and clonogenicity
The experiments already described were carried out with
freshly-isolated cBM. In many publications, fBM is fre-
quently used [33]. Therefore, we wished to compare
both isolation methods. As shown in Fig. 2a, 4.5 % ofcells processed from cBM and gated on CD45−/Ter119−
cells were Sca-1+. Figure 2b summarises a series of four
experiments in which Sca-1 expression on fBM and
cBM cells was compared. As shown, compared with
fBM, cells isolated from cBM were significantly enriched
for Sca-1+ cells.
Fig. 2 Effect of isolation method on surface marker expression and clonogenicity. a Cytograms displaying Sca-1 versus CD45−/Ter119− expression
in freshly isolated cBM preparations (left) and FSC versus Sca-1 of cBM CD45−/Ter119− (right). b Histograms showing a comparison of Sca-1 distribution
in fBM versus cBM. Values are mean ± SD of at least three experiments. c Evolution of Sca-1, CD44 and CD29 expression on cBM derived CD45− cells
in vitro. d CFU-F frequencies among Sca-1 sorted subpopulations of fBM versus cBM. Data are the mean ± SD of at least three independent
experiments. *p < 0.05, ***p < 0.001, Student’s t test. cBM compact bone marrow, fBM flushed bone marrow, ns not significant
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Sca-1, CD44 and CD29 expression on CD45− cells from
cBM and fBM during culture. Sca-1 expression increased
from 4 % in fresh cBM to 90 % at passage 3 (Fig. 2c).
Cells from fBM were likewise 90 % Sca-1+ by passage 3
(results not shown). CD44 expression increased from45 % in fresh cBM to 97 % at passage 3. CD29 expres-
sion was consistently around 95 % (Fig. 2c). Thus, after
three passages, cells isolated from cBM were ≥90 %
homogeneous for Sca-1, CD44 and CD29 expression yet
were distinctly heterogeneous for CD73 (Fig. 1d, e) and
for CD105 expression (results not shown). Similar
Fig. 3 Effect of oxygen tension on colony counts and size. a CFU-F
frequencies in subpopulations from fBM cultured in 21 % oxygen
(normoxia) or 5 % oxygen (hypoxia). b CFU-F frequencies in
subpopulations from cBM cultured in 21 %, 5 % or 2 % oxygen. Data
are the mean ± SD of at least three independent experiments, one-way
ANOVA. c Colonies from the indicated populations of sorted cBM. ‘Bulk’
refers to unseparated cells. d Summary of colony size for the different
subpopulations in 21 %, 5 % or 2 % oxygen. Data are the means ±
standard error of the mean of >100 colonies from at least three
independent experiments. *p <0.05, **p <0.01, one-way ANOVA.
cBM compact bone marrow, fBM flushed bone marrow, O2 oxygen
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sults not shown).
Next, we wanted to determine the CFU-F frequencies
among CD45−/Ter119− cells from fBM versus cBM
sorted for Sca-1 expression. As shown in Fig. 2d, com-
pared with unsorted (‘bulk’) CD45−/Ter119− cells, the
CFU-F frequency was always higher among Sca-1+ ver-
sus Sca-1− FACS sorted cells in both bone marrow prep-
arations. A greater number of CFU-F could thus be
recovered from cBM samples, and this was particularly
the case for Sca-1+ cells (Fig. 2d).
Effect of oxygen tension on colony counts and size
Recently, hypoxia has been used to improve the in-vitro
growth of MSCs [23]. We therefore compared the CFU-
F frequencies of cells cultured under normoxic (21 %
oxygen) versus hypoxic (5 % oxygen) conditions. For
fBM, hypoxia improved CFU-F frequencies in both bulk
and Sca-1− subpopulations (Fig. 3a). Given that the over-
all CFU-F frequencies were higher among cBM, we de-
cided to compare two hypoxic concentrations (2 % and
5 % oxygen) on cells from cBM. As shown in Fig. 3b
there was a slight increase in CFU-F correlated with the
degree of hypoxia for the bulk and Sca-1− cells, but the
difference between 2 % and 5 % oxygen was not statisti-
cally significant.
As already mentioned (Fig. 2d), CFU-F frequencies
and recovery were higher among cBM and therefore
cBM was used for all subsequent experiments. When
counting CFU-F, we realised there were size differences
between colonies. Indeed whereas ‘bulk’ CD45−/Ter119−
cells showed heterogeneity in CFU-F colony size, there
was a dramatic difference between Sca-1− (small col-
onies) and Sca-1+ (large colonies) sorted subpopulations
(Fig. 3c). To quantify this difference, we used the Kodak
Imager 4000 software to measure the sizes of individual
colonies. Raw data of the size distribution of >100 colonies
from four independent experiments are summarised in
Fig. 3d. The mean colony diameter of Sca-1+ cells is in-
creased with the degree of hypoxia (Fig. 3d). However,
Sca-1− cells seem to be little or not affected by oxygen
levels. As shown by FSC-A histograms (Figure S3A in
Additional file 7), freshly isolated Sca-1+ cells are signifi-
cantly larger than their Sca-1− counterparts. During in-vitro
expansion, these differences lose significance (Figure S3A,
B in Additional file 7). Morphologically, CFU-F formed
by Sca-1+ and Sca-1− cells showed differences in pheno-
type, with Sca-1− cells exhibiting a small, cobblestone-
like phenotype versus a larger, fibroblast-like phenotype
for Sca-1+ cells (see Figure S3C in Additional file 7).
Use of Sca-1 as a selection marker for MSC isolation
Next we examined the differentiation capacity of
Sca-1+ and Sca-1− cells to the osteocyte, adipocyte andchondrocyte lineages. After two passages, cells were
transferred to the corresponding differentiation condi-
tions, and after a further 14 days cells were analysed for
osteocyte and adipocyte differentiation; chondrocyte
differentiation was measured after 21 days. As shown in
Fig. 4a, both Sca-1+ and Sca-1− cells differentiated along
the osteocyte and adipocyte lineages; however, Sca-1−
cells showed increased differentiation to chondrocytes
as demonstrated by Safranin-O staining for proteogly-
cans (Fig. 4a, lower panel). This was confirmed by quan-
tification for sulfated glycosaminoglycans (S-GAG) with
an approximately threefold greater S-GAG content in
Fig. 4 Use of Sca-1 as a selection marker for MSCs. a Sca-1+ and sca-1− from cBM were cultured in osteogenic (upper), adipogenic (middle) and
chondrogenic (lower) differentiation media followed by Alizarin Red S (upper), Oil Red O (middle) or Safranin O (lower) staining. Osteogenic and
adipogenic images, bar = 100 μm; chondrogenic images, bar = 200 μm. b Chondrogenic pellet cultures from the indicated subpopulations
assayed for S-GAG content. c Fold change of Sca-1+ relative to Sca-1− expression of stem and lineage-specific gene transcripts in freshly isolated
and cultured (passage 2 (p2)) cells. Fold change of relative expression of transcripts associated with chondrogenesis in d freshly isolated Sca-1− versus
Sca-1+ sorted cells and e cultured articular chondrocytes versus cultured Sca-1− cells. Data are the mean ± SD of at least three independent
experiments. **p <0.01, Student’s t test. s-GAG sulfated glycosaminoglycans
Baustian et al. Stem Cell Research & Therapy  (2015) 6:151 Page 8 of 13Sca-1− cells (Fig. 4b). No significant difference between
the two subpopulations in osteogenic or adipogenic dif-
ferentiation was found (data not shown).
To address whether cells freshly isolated from cBM
were likewise chondrocyte ‘primed’, we investigated
expression of transcripts characteristic of stem cells
(NANOG, TERT), osteocytes (BMP2), myogenic/adipo-
cytes (Myf5) and chondrocytes (Col2a1) in both Sca-1
subpopulations by quantitative RT-PCR. In these experi-
ments, transcripts for β2M served as endogenous
control. In freshly isolated cBM cells, expression of tran-
scripts for NANOG, TERT, BMP2 and Myf5 were con-
siderably higher (500-fold to 800-fold) among Sca-1+
cells relative to Sca-1− cells (Fig. 4c). In contrast, expres-
sion of Col2a1, a chondrocyte-specific gene, was consider-
ably downregulated among Sca-1+ relative to Sca-1− cells
(50-fold reduction in expression). Upon culture in hypoxia
(passage 2), the expression of NANOG and TERT
remained unchanged, the expression of BMP2, Runx1 andMyf5 decreased (30-fold to 300-fold) and Col2a1 was fur-
ther downregulated. This indicated a higher expression of
Col2a1 in the Sca-1− population in both freshly isolated
and cultured cells (Fig. 4c).
To investigate further the chondrogenic capacity of
Sca-1− cells, we looked in more detail at transcripts for
genes specific for chondrocyte differentiation. Tran-
scripts of the chondrogenic genes ACAN, Sox9, Col2a1
and Sox6 were at least fivefold higher in Sca-1− relative
to Sca-1+ cells with the greatest difference observed in
Col10a1 expression (Fig. 4d). Minimal differences were
observed in Runx2 and Sox5 expression levels.
To compare the relative levels of chondrocyte-specific
genes in freshly isolated Sca-1− cells versus mature
chondrocytes, primary chondrocytes were isolated from
the knees of adult C57Bl/6 mice and cultured for 10 days
in 5 % hypoxia prior to RNA extraction. Primary articu-
lar chondrocytes generally showed a higher expression
for all chondrogenic transcripts relative to Sca-1− cells
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fourfold for Sox5, Sox6 and ACAN to approximately
eightfold for Sox9, Col2a1 and Runx2. The exception
was Col10a, where expression was 11-fold less in articu-
lar chondrocytes versus freshly isolated Sca-1− cells
(Fig. 4e).
PDGFRα+/CD90+ subpopulation shows an increased CFU-F
frequency
Based on the results, Sca-1+ cells were clearly enriched
in transcripts for the stem cell genes NANOG and
TERT (Fig. 4c) and showed the greater CFU-F yield. We
therefore decided to further subdivide Sca-1+ cells.
PDGFRα in conjunction with Sca-1 has been used previ-
ously to purify mMSCs from cBM on a single cell level
with a reported CFU-F frequency of 1/22.5 [20]. To fur-
ther increase the CFU-F frequency of freshly single-cell
sorted mouse bone marrow, we additionally stained cellsFig. 5 Clonal isolation of the PDGFRα+/CD90+ subpopulation. a Gating stra
initially gated on FSC and SSC followed by CD45−/Ter119− cells (upper). Gated
into the four CD90/PDGFRα subpopulations (lower right) where percentages i
cBM. c Bright-field images of expanded cells of the indicated subpopulation a
cBM (middle) and PDGFRα+CD90+Sca-1+ cBM (right) cells. Expanded PDGFRα+
media. First column = 4× magnification (image bar = 200 μm) and secon
curve for PDGFRα+/CD90+ colonies during in-vitro expansion. h Represe
CD28 stimulated splenocytes with and without addition of cloned PDGF
dashed line, unstimulated splenocytes). Bar = 200 μm. i Percentage immu
compact bone marrow, fBM flushed bone marrow, MSC mesenchymal stwith CD90, a marker used for the characterisation of
human MSCs and consistently expressed by freshly-
isolated mMSCs (Fig. 1d). We subdivided the CD45
−/Ter119−/Sca-1+ population into four distinct subpopu-
lations of PDGFRα/CD90-expressing cells (Fig. 5a). The
distribution of these subpopulations in freshly harvested
bone marrow was similar in fBM and cBM (data not
shown). The percentages of bone marrow cells express-
ing these surface markers for cBM are shown in Fig. 5b.
When expanded in vitro, PDGFRα+/CD90+ from cBM
showed a spindle-shaped, fibroblastic morphology typical
for MSCs (Fig. 5c), whereas the PDGFRα−/CD90− and
PDGFRα−/CD90+ cell populations generated cobblestone-
like morphologies. When compared with unfractionated
Sca-1+ cells, the CFU-F frequency in fBM and cBM was
1/513 and 1/251 respectively (Fig. 5d). Single-cell sorted
PDGFRα+/CD90+/Sca-1+ from cBM yielded a CFU-F fre-
quency of 1/4.tegy for the single-cell isolation of PDGFRα+/CD90+ cells. Cells were
Sca-1+ cells among CD45−/Ter119− cells (lower left) are then subdivided
n each quadrant are indicated. b Distribution of subpopulations in fresh
fter 10 days of culturing. d CFU-F frequencies of Sca-1+ cells in fBM (left),
/CD90+ cells after 7 days in e adipogenic and f osteogenic differentiation
d column = 10× magnification (image bar = 100 μm). g Survival
ntative histogram of CFSE staining among gated T cells of CD3/
Rα+/CD90+ cells (white, solid line, stimulated splenocytes; tinted,
nosuppression among different subsets of T lymphocytes. cBM
romal cell, PDGFRα platelet-derived growth factor receptor alpha
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vidual clones were expanded for several days and pas-
saged at 10, 14 and 18 days. During this time not all
clones continued growing, and by 18 days approximately
40 % of initially-plated clones survived (Fig. 5g). Surviv-
ing clones were divided and exposed to media for osteo-
genic and adipogenic differentiation, but unfortunately
none of the cells survived after 14 or 21 days of in-vitro
differentiation. After 7 days of in-vitro differentiation,
lipid vacuoles could be seen in osteogenic and adipo-
genic differentiating cultures (Fig. 5e, f ).
In control medium, clones were tested for their ability
to inhibit the proliferation of CD3/CD28-stimulated T
cells. All 12 clones tested in this assay showed potent
inhibitory activity on T-cell proliferation at an MSC:T-
cell ratio of 1:100. A result from a representative clone
is shown in Fig. 5h. Additional staining with CD4 and
CD8 monoclonal antibodies revealed a simultaneous
degree of inhibition of proliferation in both T-lymphocyte
subsets mediated by cloned PDGFRα+/CD90+ cells
(Fig. 5i).
Discussion
In this study, we have used flow cytometry to analyse
the evolution of surface markers on cultured mMSCs
and to use a combination of markers to prospectively
isolate, with high efficiency, clonal populations that had
immune regulatory properties. This approach will enable
the use of genetically modified mouse strains to further
investigate the basic biology of MSCs. Similar experi-
ments could be done with human cells in order to im-
prove and harmonise human MSC preparations. Until
recently [20, 34], most experiments with mMSCs have
been conducted with unsorted, uncloned cells—so-called
‘bulk’ MSCs. As shown in Fig. 1, without sorting ‘bulk’
MSCs are heterogeneous, containing myeloid cells at
early passages, and are a phenotypically evolving collec-
tion of cells. Our phenotypic analysis of CD45−/TERE119−
bone marrow cells showed a change in composition of
cells expressing the human MSC markers CD73, CD90
and CD105 (Fig. 1d, e) and the mMSC markers CD44 and
Sca-1 (Fig. 1g).
Human MSCs have been studied intensively and are
already used in clinical trials [35, 36]. CD73, CD90 and
CD105, among others, are routinely used for the defin-
ition of human MSCs [32]. Unfortunately these
markers are not MSC specific and, as reviewed recently
[33], expression varies on passaging. mMSCs also ex-
hibit heterogeneous staining for these markers, making
their use in prospective isolation methods problematic
[37]. Among CD45−/Ter119− fresh bone marrow cells,
CD73−/CD90− cells represent a major population, but
only a minor population (3 %) in passage 1 expanded
cells (Fig. 1e). The low percentage of these cells in earlypassages suggests that they do not survive well in vitro.
As reported previously [8], CD73 is barely detected on
freshly isolated cells, but is highly expressed on cul-
tured cells. The slow increase over time of CD73 ex-
pression (Fig. 1d, e) and reports on its upregulation in
hypoxia [38] support the assumption of marker upregu-
lation upon culturing. CD90 (Thy-1) was originally a
prototypic T-cell marker but was later found to be
expressed on human MSCs. However, its expression on
cells from C57Bl/6 mice is controversial, with groups
claiming its absence [5, 6] or its presence [18, 20] on
mMSCs. In our experience, CD90 can be used as a reli-
able marker for the prospective isolation of mMSCs
(Fig. 5).
Additional analysis showed that expression of both
CD44 and Sca-1 antigens increased upon culturing.
This is somewhat expected given that expression of
both antigens can be regulated upon cell signalling
[10, 39]. CD44 is well established as an activation
marker on mouse and human T cells [39]. CD44 is
used frequently as a marker to define mMSCs [40, 41],
yet recent research has shown that CD44 might not be
a useful marker for the isolation of MSCs because
MSCs could be isolated from sorted CD44− cells and
because CD44 was acquired in vitro [41]. We showed
herein that gated CD45−/Sca-1+ fresh fBM and cBM
cells were also CD44− and that CD44 was acquired
in vitro (Fig. 1g). Additional experiments focused on Sca-1
expression, showing that Sca-1 was acquired by sorted
Sca-1− cells (Fig. 1G) [6, 19, 42]. Given that the possible
contamination of sorted Sca-1− cells by Sca-1+ was at
most 2 %, and the kinetics of Sca-1+ cell growth, the
simplest interpretation of these results is that Sca-1 was
acquired by cultured Sca-1− cells rather than being the
result of outgrowth from Sca-1+ contaminants.
Currently, two major isolation methods are used to
isolate mMSCs from bone marrow. The traditional
method consists of flushing out the bone marrow
(fBM) and using mechanical sheer force to obtain
single-cell suspensions. This may leave behind poten-
tial stem/progenitor cells residing at the endosteum.
By collagenase digestion of bone fragments (cBM),
endosteum residing cells can be harvested and purified
using flow cytometry. A general conclusion from our
studies was that the CFU-F frequency was considerably
higher among such cBM cells (Fig. 2b). There is gen-
eral agreement that MSCs in the bone marrow, and the
HSCs which they support, can be found at different
anatomical locations that differ also in oxygen avail-
ability (reviewed in [22]). Many such MSC/HSC niches
are found close to cortical bone in a relatively hypoxic
environment and therefore, for maximum CFU-F re-
covery, crushing bones followed by collagenase diges-
tion is clearly advantageous.
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from either fBM or cBM were sorted based upon Sca-1
expression, the CFU-F colony size varied significantly be-
tween subpopulations (Fig. 3c, d). Although differences in
CFU-F colony size have been reported previously [43], to
our knowledge this is the first report indicating differences
in colony size among freshly isolated MSC subpopulations
sorted based upon surface marker expression. Although
Sca-1+ cells were slightly larger by FSC-A than their Sca-1−
counterparts (Additional file 7), cell size alone is unlikely
to explain differences in colony size. Additionally, hypoxia
had an effect both on CFU-F frequency (Fig. 3b) and aver-
age colony size (Fig. 3d). This was particularly the case for
Sca-1+ cells (Fig. 3d). This could imply that the majority
of Sca-1+ cells are located close to the endosteum where
oxygen levels are low [22]. In summary, hypoxia improved
CFU-F frequency among Sca-1− cells (Fig. 3b) but had lit-
tle effect on cell growth (Fig. 3d). In contrast, hypoxia did
not improve CFU-F frequency among Sca-1+ cells but did
improve their growth. The improvement in both CFU-F
frequency and cell growth of bulk MSCs in hypoxia is
readily explained by the fact that ‘bulk’ MSCs contain a
mixture of Sca-1+ and Sca-1− cells. The poor chondro-
genic differentiation capacity of ‘bulk’ mMSCs might also
be a result of the low CFU-F frequency of the more chon-
drogenic Sca-1− population.
Taken together, the smaller size of colonies, the lower
CFU-F frequency and the lack of a significant response
of Sca-1− cells to hypoxia may suggest they reside in
different anatomical locations and represent less differ-
entiated cells. In analogy with haematopoiesis, differ-
ences in mean colony size could indicate different
stem/progenitor subpopulations [44]. Slowly prolifer-
ating stem cells would thus form smaller colonies
appearing later in culture than rapidly proliferating
progenitors forming early, larger colonies. However,
our transcriptomic analysis of freshly isolated Sca-1+
and Sca-1− cells indicated the opposite, with higher
levels of NANOG and TERT expression among Sca-1+
cells (Fig. 4c). We have shown that both Sca-1+ and
Sca-1− cells have the capacity to give rise to osteoblasts,
chondrocytes and adipocytes (Fig. 4a). In addition, and
confirming results from differentiation assays (Fig. 4a),
the Sca-1− subpopulation appeared to express increased
levels of transcripts characteristic of chondrogenesis
(Fig. 4d). The Sca-1− in-vitro differentiation to chondro-
cytes, as measured by GAG accumulation (Fig. 4b), was
thus superior to that of Sca-1+ cells. Indeed, in a recent
publication, Chan et al. [45] identified a similar pro-
chondrogenic progenitor in mouse bone marrow. Inter-
estingly, it has been shown that Sca-1−/− mice develop
age-related osteoporosis owing to reduced numbers of
osteoprogenitors and osteoblasts and display a weak-
ened bone structure and bone material caused by thereduced number of MSC; this also resulted in impaired
adipogenesis in vitro [46].
In the seminal paper by Morikawa et al. [20], cells
sorted from cBM with the CD45−, Ter119−, Sca-1+ and
PDGFRα+ (so-called PαS markers) phenotype had a
CFU-F frequency of 1/22.5. Individual colonies were
isolated and some had in-vitro tri-lineage differentiation
potential even following re-isolation from in vivo, indi-
cating the existence of true mesenchymal stem cells. We
have directly sorted single cells from bone marrow and,
in addition to PDGFRα, have used CD90 expression as a
selection marker. As shown in Fig. 5b, this combination
of markers allows the isolation of CFU-F with a frequency
of 1/4 among PDGFRα+/CD90+ cells. This represents a
higher frequency than previously reported by Morikawa
et al., most probably because CD90−/PDGFRα+ cells, com-
prising about 1/3 Sca-1+/PDGFRα+ cells, failed to grow
in vitro (Fig. 5c, lower right). In addition to the increase in
CFU-F frequencies, morphological differences between
subpopulations of sorted cells were also evident (Fig. 5c).
The full implication of these differences in cell morph-
ology requires additional investigation beyond the scope
of this manuscript.
Despite an initial high plating efficiency of sorted
Sca-1+/PDGFRα+/CD90+ cells, their continued in-vitro
growth was limited (Fig. 5g), a finding reminiscent of
mouse T-cell cloning experiments. This was particularly
evident when CFU-F clones were transferred to differen-
tiation medium. Recently, dramatic changes in behaviour
of clonal populations of mMSCs have been reported
[47]. The authors suggest that isolation of individual
cells from within a bulk population may alter the cell’s
genetic programme. Despite our failure to show complete
tri-lineage differentiation of clones, in control cultures
some clones continued to expand, allowing their im-
munosuppressive properties to be analysed. As shown
in Fig. 5h, i, such clones strongly inhibited the in-vitro
division of activated T cells.
Conclusion
We have recently shown that mMSCs respond to
hypoxia by upregulating transcripts for stem cell genes
resulting in improved growth and differentiation [23].
We have taken advantage of these results to prospect-
ively isolate and clone MSCs from C57Bl/6 bone
marrow. By positive selection using a combination of
antibodies to Sca-1, CD90 and PDGFRα and culturing in
hypoxia, we have found a subpopulation of CD45
−/Ter119− bone marrow cells from C57Bl/6 mice with
a CFU-F cloning efficiency of 1/4. Individual clones
suppressed T-cell proliferation, thereby revealing im-
munosuppressive properties. To our knowledge, these
results represent the highest frequencies of mMSC clon-
ing from C57Bl/6 mice so far reported.
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Additional file 1: Table S1. Presenting a summary of monoclonal
antibodies used in the experiments. (XLSX 9 kb)
Additional file 2: Figure S1. Showing the representative gating
strategy for flow cytometric analysis. Cells were gated based on their size
and granularity (upper left) and doublets were excluded based on FSC-A
versus FSC-H (upper right). CD45+ and non-viable (PI+) cells were gated
out (lower left) and quadrant gates were drawn based on fluorescent
minus one controls containing matched antibody isotypes (lower right).
(TIFF 231 kb)
Additional file 3: A document presenting the methods for FACS
and gelatine coating. For FACS, cells isolated from fBM or cBM were
resuspended in ice-cold FACS buffer and stained for 30 minutes at 4 °C
in the dark with previously optimised concentrations of monoclonal
antibodies listed in Additional file 1. The labelled cells were washed twice,
filtered through a 40 μm filter, resuspended in FACS sorting buffer at
concentrations between 10 × 106 and 20 × 106 cells/ml and sorted using
a BD FACSAriaII® sorter fitted with a 70 μm nozzle for fBM and an 85 μm
nozzle for cBM derived cell suspensions The BD FACSAriaII® optical
configuration and corresponding fluorochomes/dyes used is defined in
Additional file 4. SYTOX® blue dead cell stain (Life Technologies) was used
for dead cell exclusion and added just prior to the sort (Additional file 2).
Cell doublets were excluded based on FSC-A versus FSC-H and fluorescence
minus one controls were used to define the position of the gates. Where
appropriate, the purity of sorted cell subsets was determined with
purities >95 % observed. FACS single cells were seeded on plastic or
gelatine-coated 96 well plates. For gelatine coating, 96-well flat-bottom
plates were coated with 0.1 % gelatine and incubated for 2 hours at
room temperature. Gelatine was removed and the vessels were
incubated for 1 hour at 37 °C. Gelatine-coated vessels were used
immediately or stored at 4 °C in Dulbecco’s PBS for a maximum of
2 weeks. (DOCX 81 kb)
Additional file 4: Table S2. Presenting the optical configuration and
corresponding fluorochomes/dyes of the BD FACSAriaII® cell sorter.
(XLSX 9 kb)
Additional file 5: Table S3. Presenting the sequences of quantitative
RT-PCR primers used in the experiments. (XLSX 9 kb)
Additional file 6: Figure S2. Showing characterisation of CD45
hematopoietic cells. A Ratio of SSC-A between CD45− and CD45+ cells.
B Co-expression of CD45 and F4/80 (black, CD45 only; grey, CD45+
F4/80). Data are the mean ± SD of at least three independent
experiments. (TIFF 61 kb)
Additional file 7: Figure S3 Showing the size and colony appearance
of Sca-1 subpopulations. A Size differences in freshly isolated Sca-1
subpopulations from cBM. B Size differences in cultured Sca-1 subpopulations.
Bright-field images of C Sca-1− and D Sca-1+ expanded colonies after
10 days of culture. First column = 4× magnification (bar = 200 μm) and
second column = 10× magnification (bar = 100 μm). Data are the
mean ± SD of at least three independent experiments. *p <0.05, Student’s
t test. (TIFF 1643 kb)Abbreviations
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